Last Thursday, our Team participated in The Leukemia & Lymphoma Society's Light the Night event in Manhattan's South Street Seaport for the third year in a row to raise funds and awareness for blood cancer patients. It was a powerful reminder of the importance of our work as we walked to bring light to the darkness of cancer alongside an inspiring community of patients, survivors, and their loved ones 🧡🏮
OncoPrecision
Biotechnology Research
Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.
About us
Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.
- Website
-
http://oncoprecision.bio
External link for OncoPrecision
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- New York
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Oncology
Locations
-
Primary
180 Varick St
6th Floor
New York, 10014, US
-
Córdoba, AR
Employees at OncoPrecision
Updates
-
Our Team wore pink for the #InternationalDayAgainstBreastCancer to raise awareness about breast cancer and promote early detection, diagnosis, and treatment 🩷🎀
-
October is #BreastCancerAwarenessMonth 🎀🎀 - Breast cancer is a disease in which malignant cells form in the tissues of the breast - When detected early, the 5-year relative survival rate for localized breast cancer is 99% - Breast cancer also affects men, who account for about 1% of cases - Symptoms may include a lump in a breast, breast warmth and itching, and nipple changes and discharge - Over 2 million women worldwide are diagnosed with breast cancer per year - Maintaining a healthy weight can reduce the risk of breast cancer
-
We’re thrilled to have been awarded a Golden Ticket, which will cover a year’s rent for one of our Wet Lab Scientists at our New York City HQ. Thank you Biolabs@NYULangone and New York City Economic Development Corporation for your support 🧡🏆🗽
Huge thanks to everyone who attended the New York City Economic Development Corporation Golden Ticket Pitch Event in partnership with Biolabs@NYULangone! We watched #innovation come to life as 11 incredible #startups pitched their ideas to a panel of industry leaders notably Dr. Glennis Mehra, Jonathan Schulhof, Amit Duvshani and LAURENCE BLUMBERG, MD. Congratulations to the finalists and a special shoutout to our winners Synthis Therapeutics, Inc., Aggregate Biosciences and OncoPrecision who each received a coveted 2024 New York City Economic Development Corporation Golden Ticket! A special thank you to New York City Economic Development Corporation for their ongoing support in driving life sciences innovation forward! We are excited to see what the future holds for these startups #biotech #innovation #support #NYCEDC #networking #goldenticket
-
+15
-
September is #BloodCancerAwarenessMonth 🩸🩸 - Blood cancer accounts for the majority (~25%) of childhood cancer cases - There are over 100 types of blood cancer, including types of Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndromes (MDS), and Myeloproliferative Neoplasms (MPNs) - Symptoms may include exhaustion, recurring fever, random aches, and night sweats - The risk factors associated with blood cancers aren't fully understood - Blood cancers often begin in the bone marrow and are usually the result of an abnormal reproduction of white blood cells
-
We're thrilled to share that our CEO, Tarek Ali Zaki, has been named Entrepreneur of the Year in the Emerging category by EY Argentina. We celebrate this achievement as a Team and are thankful for the recognition of our work. As Tarek said during his acceptance speech "The true prize will be the day our efforts result in an improvement for cancer patients." A profound thank you to EY for this award and to our Team, clinical partners, investors, and pharmaceutical partners for your continued support on this Mission. — Nos alegra enormemente compartir que nuestro CEO, Tarek Ali Zaki, ha sido nombrado Emprendedor del Año en la categoría Emergente por EY Argentina. Celebramos este logro como Equipo y agradecemos el reconocimiento a nuestro trabajo. Como dijo Tarek durante su discurso de aceptación: "El verdadero premio será el día en que nuestros esfuerzos resulten en una mejora para los pacientes oncológicos." Un profundo agradecimiento a EY por este premio y a nuestro Equipo, socios clínicos, inversores y socios farmacéuticos por su continuo apoyo en esta Misión.
-
Our CSO, Dr. Gastón Soria, will be speaking at the upcoming Masters Argentina Conference this Saturday which will be held at Columbia University. The annual conference gathers business and political leaders from Argentina to discuss the country's opportunities and challenges. Register here: https://lnkd.in/dM5GgMxv — Nuestro CSO, el Dr. Gastón Soria, hablará este sábado en la Conferencia Masters Argentina que se llevará a cabo en la Universidad de Columbia. La conferencia anual reúne a líderes empresariales y políticos de la Argentina para discutir las oportunidades y los desafíos del país.
-
Less than one week to go for the New York Institute of Technology 2024 Biotechnology Conference, where our CEO will be participating in a panel discussion on Emerging Biotechnology Companies. The conference will be held both in-person at NYIT's Long Island campus and remotely via Zoom. We hope to see you there! https://lnkd.in/dWbuNq8k — Falta menos de una semana para la New York Institute of Technology 2024 Biotechnology Conference, donde nuestro CEO participará en un panel de discusión sobre Empresas de Biotecnología Emergentes. La conferencia se llevará a cabo tanto en persona en el campus de NYIT en Long Island como de forma remota a través de Zoom. ¡Esperamos verl@s ahí!